PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
61.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
30.67%
Positive revenue growth while 1177.HK is negative. John Neff might see a notable competitive edge here.
37.54%
Positive gross profit growth while 1177.HK is negative. John Neff would see a clear operational edge over the competitor.
106.77%
EBIT growth below 50% of 1177.HK's 271.73%. Michael Burry would suspect deeper competitive or cost structure issues.
-3.87%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
104.84%
Net income growth under 50% of 1177.HK's 719.19%. Michael Burry would suspect the firm is falling well behind a key competitor.
104.88%
EPS growth under 50% of 1177.HK's 735.21%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
104.88%
Diluted EPS growth under 50% of 1177.HK's 735.21%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.29%
Slight or no buybacks while 1177.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.29%
Slight or no buyback while 1177.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
24.80%
OCF growth of 24.80% while 1177.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
22.77%
FCF growth of 22.77% while 1177.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-46.01%
Negative 10Y revenue/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
11235.06%
5Y revenue/share CAGR above 1.5x 1177.HK's 149.83%. David Dodd would look for consistent product or market expansions fueling outperformance.
861.29%
3Y revenue/share CAGR above 1.5x 1177.HK's 68.09%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-130.40%
Negative 10Y OCF/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
40.30%
Below 50% of 1177.HK's 162.99%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
32.39%
3Y OCF/share CAGR at 50-75% of 1177.HK's 56.51%. Martin Whitman would suspect weaker recent execution or product competitiveness.
-94.86%
Negative 10Y net income/share CAGR while 1177.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
120.89%
Below 50% of 1177.HK's 4073.69%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
101.17%
Below 50% of 1177.HK's 1687.71%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
-9.56%
Negative 5Y equity/share growth while 1177.HK is at 518.98%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-24.09%
Negative 3Y equity/share growth while 1177.HK is at 308.63%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 1177.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while 1177.HK stands at 189.93%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
67.60%
Inventory growth well above 1177.HK's 3.72%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.84%
Negative asset growth while 1177.HK invests at 33.48%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.16%
We have a declining book value while 1177.HK shows 52.26%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-71.03%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
132.92%
SG&A growth well above 1177.HK's 24.44%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.